Delhi Fake Cancer Drug Racket: Nearly 100 Patients Traced as Police Probe ₹9-Crore Medicine Scam

Investigators probing the August 2026 fake cancer medicine racket have traced nearly 100 patients who allegedly received medicines diverted from hospitals and chemist shops in Haryana and Telangana
Capsules and tablets on blue background.
Nearly 100 cancer patients have been traced in a Delhi fake medicine racket. SHVETS production/Pexels
Published on: 
Updated on: 

In August 2026, Delhi police busted a racket of fake cancer medicine. Police have traced nearly 100 cancer patients who allegedly brought medicines diverted from hospitals and other legitimate sources.

​The police have identified three chemist shops and four hospitals in Haryana and Telangana as alleged sources of the diverted medicines.

Investigators believe the number of patients affected by the alleged cancer medicine racket could be higher than the nearly 100 traced so far. According to The Times of India, the probe is examining hospital records, chemist shops and patient details to reconstruct the route taken by each vial. Investigators are also checking whether patients whose medicines were diverted missed prescribed doses and whether any treatment interruptions affected their health. The exact quantity of medicines allegedly diverted and sold is still being established.

​According to the reports, in August, Delhi police recovered 588 filled anti-cancer vials, six empty vials and medicines worth approximately Rs. 9 crore.

​17 people were arrested in the racket involving fake cancer medicine.

​The medicines that were recovered included Darzalex, Imfinzi, Erbitux, Opdyta, Gazyva, Bavencio, Adcetris, and Keytruda. All these medicines are used for cancer treatment and immunotherapy and are each worth lakhs of rupees per dose. The people involved in the racket had supply links in Delhi NCR, Mumbai, Hyderabad, Haryana and Uttar Pradesh.

How Did the Fake Cancer Medicine Racket Operate?

According to Delhi Police, the alleged network sourced medicines through three routes: counterfeit drugs obtained from unauthorised sources, genuine medicines allegedly diverted from hospitals, and medicines diverted from government institutions and warehouses. Investigators said the accused allegedly removed batch numbers and maximum retail price (MRP) details and repackaged the medicines to conceal their origins. The police investigation is examining the supply chain and the people allegedly involved at different stages.

​On June 22, 2026, the investigation began after police received information about a bunch of people who were procuring, storing and selling counterfeit and illegally diverted anti-cancer drugs.

​On 11 July, seven teams conducted raids in association with the drug department to find these people from various locations.

​According to the investigators, the vials that were meant for other patients were misappropriated and sold in the market for Rs. 1 lakh - Rs. 1.3 lakh per vial.

​According to a report by ETV Bharat on a separate case, cancer treatment injections originally meant to be sold for free to patients of a Rajasthan government hospital were diverted and found in the grey markets of Delhi. The same medicines were sold at a much higher price. Around 22 vials were confiscated, which were being sold for Rs. 1 lakh each.

Rajasthan Probe Raises Further Concerns Over Cancer Drug Safety

In a related development, Rajasthan authorities ordered an inquiry after four vials of Bavencio (avelumab), reportedly supplied to a government cancer treatment institute in Bikaner, were allegedly recovered in Delhi. The hospital said its records accounted for the medicines received and administered.

A subsequent NDTV Rajasthan report published on August 26, 2026, cited testing that found lower-than-expected drug content and bacterial contamination in samples from two batches. The findings raised further questions about medicine quality and supply-chain oversight. The reported test results relate to the samples examined and should not be generalised to all medicines seized in the Delhi racket.

Counterfeit Cancer Drugs in India: Risks of Fake and Diverted Medicines

According to the World Health Organisation, 1 in 10 medical products in low- or middle-income countries is substandard or falsified. Anti-Cancer medicines, which are expensive and distributed through a complicated supply chain, are more prone to such scams.

​According to the reports, cancer medicines are attractive to such crimes because of their high price, unavailability in many markets and the desperation of patients who are battling through an advanced stage of the disease.

Delhi Fake Cancer Drug Racket: Nearly 100 Patients Traced

Police have spoken to several family members and patients who had bought the illegally diverted medicines, but according to the police, none of these people was aware that the medicines were originally meant for other patients or sold through sellers who were part of a corrupt racket chain.

​The police are doing an extensive investigation to find out the exact chain of events that went through before the medicines reached the patients. To understand the pattern, police are tracing back hospital records, chemist shops and patient details.

​Investigations are ongoing to establish where each vial came from and who the people involved were in diverting it and selling it to another patient. Most of the patients who had bought the medicines are from Haryana.

​According to the reports, three chemist shops and four private hospitals in Haryana and Telangana have been identified as the alleged sources of the misappropriated medications.

​A source told TOI, "Most of the patients for whom the vials were legitimately issued were also from Haryana, but the medicines were allegedly misappropriated and sold to others. Some of these patients have been examined by police.”

​Investigators are trying to find out whether the patients who missed their doses because of the diversion of medicines had to face any health-related consequences.

​To strengthen their case, police want to ask doctors at a top hospital how missing a treatment cycle affects a patient's health.

Pills and medicines.
India's counterfeit oncology drug crisis is not just a regulatory failure; it is a healthcare financing failure.Rūdolfs Klintsons /Pexels

India’s Cancer Drug Crisis Is Also a Healthcare Financing Problem

According to the data, around 14 lakh new cases of cancer are diagnosed in India every day, which makes for an immense demand in the market for anti-cancer drugs.

​Only a fraction of this population has health insurance that can cover the high costs of cancer treatment and medications. So people who are suffering from cancer in the country try to find alternative ways to source the medicines, and that is when the corrupted supply chains come into play.

​Ultimately, India's counterfeit oncology drug crisis is not just a regulatory failure; it is a healthcare financing failure.

(Rh/ARC/MSM)

Capsules and tablets on blue background.
Fake Cancer Drugs Allegedly Supplied to Over 90 Bengaluru Hospitals; Pharmacy Owner Arrested